EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular Magnetic Resonance for Lifelong Surveillance in Congenital Heart Disease: From Childhood to Adulthood

Georgios Spagos, Dimitrios Voliotis, George Koulaouzidis, Parthena Theodoridou, Sotiria Iliopoulou, Maria-Anna Bazmpani, Theodoros D. Karamitsos, Dafni Charisopoulou

Diagnostics · 16.11.2026 · 16 (22) · 3806

DOI: 10.3390/diagnostics16223806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.11.2026. Verfasst von Georgios Spagos und 7 weiteren Autor:innen. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in paediatric cardiology, surgery and catheter intervention have enabled most children with congenital heart disease (CHD) to reach adulthood, yet transfer to adult congenital heart disease (ACHD) care remains a period at risk of discontinuity and of delayed recognition of residual lesions, ventricular dysfunction, arrhythmias and aortopathy. Cardiovascular magnetic resonance (CMR) provides radiation-free, reproducible assessment of anatomy, ventricular volumes and function, flow, shunts and myocardial tissue. This narrative review examines CMR as a tool for continuous longitudinal surveillance from childhood into adult life. Its role is not to replace echocardiography but to answer questions that echocardiography cannot resolve reliably and to provide serially comparable measurements, particularly after tetralogy of Fallot repair, in systemic right ventricles, in Fontan circulation and in coarctation of the aorta. We describe lesion-specific protocols, standardised phase-contrast acquisition and ventricular contouring that permit valid serial comparison, and the clinical, electrocardiographic, biochemical (NT-proBNP) and echocardiographic triggers that prompt earlier CMR or allow it to be deferred. CMR timing should therefore follow the lesion and the patient’s trajectory rather than chronological age, with transfer regarded as one point on a continuous surveillance pathway. Limitations include examination duration, arrhythmia, device artefacts, contrast considerations and limited access to congenital imaging expertise.

Zitieren

APA

Spagos, G., Voliotis, D., Koulaouzidis, G., Theodoridou, P., Iliopoulou, S., Bazmpani, M., Karamitsos, T. D., & Charisopoulou, D. (2026). Cardiovascular Magnetic Resonance for Lifelong Surveillance in Congenital Heart Disease: From Childhood to Adulthood. Diagnostics, 16(22), 3806. https://doi.org/10.3390/diagnostics16223806

Vancouver

Spagos G, Voliotis D, Koulaouzidis G, Theodoridou P, Iliopoulou S, Bazmpani M, et al. Cardiovascular Magnetic Resonance for Lifelong Surveillance in Congenital Heart Disease: From Childhood to Adulthood. Diagnostics. 2026;16(22):3806. doi:10.3390/diagnostics16223806

BibTeX
@article{Spagos2026,
  author = {Spagos, Georgios and Voliotis, Dimitrios and Koulaouzidis, George and Theodoridou, Parthena and Iliopoulou, Sotiria and Bazmpani, Maria-Anna and Karamitsos, Theodoros D. and Charisopoulou, Dafni},
  title = {Cardiovascular Magnetic Resonance for Lifelong Surveillance in Congenital Heart Disease: From Childhood to Adulthood},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {3806},
  doi = {10.3390/diagnostics16223806}
}
Kostenlos starten →